Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 136.73 USD 0.83% Market Closed
Market Cap: 6.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+23%
Revenue
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

CRL Price Targets Summary
Charles River Laboratories International Inc

Wall Street analysts forecast CRL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRL is 150.62 USD with a low forecast of 70.7 USD and a high forecast of 225.75 USD.

CRL Lowest Forecast
Wall Street Target
70.7 USD
48% Downside
CRL Average Forecast
Wall Street Target
150.62 USD
10% Upside
CRL Highest Forecast
Wall Street Target
225.75 USD
65% Upside
Lowest
Price Target
70.7 USD
48% Downside
Average
Price Target
150.62 USD
10% Upside
Highest
Price Target
225.75 USD
65% Upside
Charles River Laboratories International Inc Competitors:
Price Targets
688222
HitGen Inc
3% Downside
G
GENO
Genovis AB
46% Upside
WAT
Waters Corp
17% Upside
WST
West Pharmaceutical Services Inc
38% Upside
688222
HitGen Inc
3% Downside
G
GENO
Genovis AB
46% Upside
WAT
Waters Corp
17% Upside
WST
West Pharmaceutical Services Inc
38% Upside
207940
Samsung Biologics Co Ltd
34% Upside
O
688238
Obio Technology Shanghai Corp Ltd
10% Upside
TECN
Tecan Group AG
35% Upside
ONT
Oxford Nanopore Technologies PLC
36% Upside

Revenue
Forecast

Revenue Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's revenue is 12%. The projected CAGR for the next 3 years is 2%.

12%
Past Growth
2%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's operating income is 10%. The projected CAGR for the next 3 years is 14%.

10%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Charles River Laboratories International Inc

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's net income is -29%. The projected CAGR for the next 3 years is 277%.

-29%
Past Growth
277%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRL's stock price target?
Price Target
150.62 USD

According to Wall Street analysts, the average 1-year price target for CRL is 150.62 USD with a low forecast of 70.7 USD and a high forecast of 225.75 USD.

What is Charles River Laboratories International Inc's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's revenue is 12%. The projected CAGR for the next 3 years is 2%.

What is Charles River Laboratories International Inc's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's operating income is 10%. The projected CAGR for the next 3 years is 14%.

What is Charles River Laboratories International Inc's Net Income forecast?
Projected CAGR
277%

For the last 8 years the compound annual growth rate for Charles River Laboratories International Inc's net income is -29%. The projected CAGR for the next 3 years is 277%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.